Q. Cheng, P. K. Law, M. de Gasparo, et al. Combination of the dipeptidyl peptidase IV inhibitor LAF237 [(S)-1-[(3-hydro- xy-1-adamantyl)ammo]acetyl-2-cyanopyrrolidine] with the an- giotensin II type 1 receptor antagonist valsartan [N-(1-oxopen- tyl)-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl]-L-valine] enhances pancreatic islet morphology and function in a mouse model of type 2 diabetes. Journal of Pharmacology and Experimental Therapeutics, 2008, 327(3): 683-691.